Related Experiment Videos
Primary cutaneous mucormycosis: a diagnosis to consider
M García-Bustínduy1, F Guimerá-Martín-Neda, A Noda
1Department of Dermatology, Medical Faculty, University of La Laguna, Tenerife, Spain. mgarciab@ull.es
Summary
Primary cutaneous mucormycosis, a fungal infection, requires prompt diagnosis and treatment, especially in diabetics and the immunocompromised. This case highlights the importance of histopathological and microbiological studies for effective management.
Area of Science:
- Mycology
- Dermatology
- Infectious Diseases
Background:
- Primary cutaneous mucormycosis is a rare, invasive fungal infection.
- It predominantly affects individuals with diabetes mellitus and compromised immune systems.
- Prompt diagnosis and treatment are crucial to prevent severe outcomes.
Observation:
- A case study of a 74-year-old male with multiple risk factors including COPD, hemolytic anemia, myelodysplastic syndrome, and corticosteroid-induced diabetes.
- The patient presented with two necrotic skin lesions on his left leg.
- Clinical suspicion of mucormycosis prompted further investigation.
Findings:
- Histopathological and microbiological examination of debrided tissue confirmed primary cutaneous mucormycosis.
- Treatment with topical and intravenous Amphotericin B led to complete ulcer healing.
- Risk factors and microbiological findings were consistent with existing literature.
Implications:
- This case underscores the necessity of suspecting mucormycosis in at-risk populations, including diabetics and immunocompromised individuals.
- Accurate diagnosis relies on comprehensive histopathological and microbiological studies to identify the causative fungal genus.
- Early and precise diagnosis facilitates timely and effective therapeutic interventions, improving patient prognosis.